Alnylam Pharmaceuticals ALNY Earnings Call Transcripts

NASDAQ ALNY
$159.85 +8.21 (+5.41%)
At close: Nov 11, 2026 · 4:00 PM EST
11 earnings calls on file for Alnylam Pharmaceuticals, from Q4 2019 to Q3 2026. Each transcript opens in a new tab.
Latest earnings call

Alnylam Pharmaceuticals Q3 2026 Earnings Call

Oct 29, 2026 8,869 words · 39 min read
  • Josh BrodskyVice President of Investor Relations
  • Yvonne GreenstreetChief Executive Officer
  • Tolga TangulerChief Commercialization Officer
  • Pushkal GargChief Research and Development Officer
Prepared remarks and the full analyst Q&A, speaker by speaker.
Earnings calls

Alnylam Pharmaceuticals Earnings Call Transcripts

Calls11
LatestOct 29, 2026
SinceQ4 2019

Fiscal 2026

Fiscal 2021

Fiscal 2020

Fiscal 2019

All 11 Alnylam Pharmaceuticals transcripts Register to get access to Alnylam Pharmaceuticals’s earnings call transcripts.